Tufton Capital Management Johnson & Johnson Transaction History

Tufton Capital Management

$532 Million
Q3 2024

A detailed history of Tufton Capital Management transactions in Johnson & Johnson stock. As of the latest transaction made, Tufton Capital Management holds 56,934 shares of JNJ stock, worth $8.29 Million. This represents 1.74% of its overall portfolio holdings.

Number of Shares

56,934

Previous 58,484 2.65%

Holding current value

$8.29 Million

Previous $8.55 Million 7.93%

% of portfolio

1.74%

Previous 1.67%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$145.48 - $167.38 $225,493 - $259,439	-1,550 Reduced 2.65%	56,934 $9.23 Million
Q2 2024 Jul 31, 2024	BUY	$144.38 - $157.78 $143,369 - $156,675	993 Added 1.73%	58,484 $8.55 Million
Q1 2024 May 07, 2024	SELL	$155.22 - $162.74 $26,076 - $27,340	-168 Reduced 0.29%	57,491 $9.09 Million
Q4 2023 Jan 31, 2024	SELL	$145.6 - $158.88 $25,480 - $27,804	-175 Reduced 0.3%	57,659 $9.04 Million
Q3 2023 Oct 30, 2023	SELL	$155.75 - $174.48 $11,214 - $12,562	-72 Reduced 0.12%	57,834 $9.01 Million
Q2 2023 Jul 28, 2023	SELL	$154.35 - $166.11 $160,369 - $172,588	-1,039 Reduced 1.76%	57,906 $9.58 Million
Q1 2023 Apr 19, 2023	SELL	$151.05 - $180.26 $343,789 - $410,271	-2,276 Reduced 3.72%	58,945 $9.14 Million
Q4 2022 Jan 26, 2023	BUY	$160.2 - $179.79 $264,169 - $296,473	1,649 Added 2.77%	61,221 $0
Q3 2022 Oct 21, 2022	SELL	$161.33 - $179.52 $2.88 Million - $3.21 Million	-17,880 Reduced 23.09%	59,572 $9.73 Million
Q2 2022 Jul 20, 2022	SELL	$168.19 - $186.01 $92,840 - $102,677	-552 Reduced 0.71%	77,452 $13.7 Million
Q1 2022 Apr 25, 2022	SELL	$158.14 - $179.59 $156,084 - $177,255	-987 Reduced 1.25%	78,004 $13.8 Million
Q4 2021 Jan 28, 2022	BUY	$155.93 - $173.01 $83,422 - $92,560	535 Added 0.68%	78,991 $13.5 Million
Q3 2021 Oct 21, 2021	SELL	$161.5 - $179.47 $106,428 - $118,270	-659 Reduced 0.83%	78,456 $12.7 Million
Q2 2021 Jul 29, 2021	SELL	$159.48 - $171.07 $194,565 - $208,705	-1,220 Reduced 1.52%	79,115 $13 Million
Q1 2021 Apr 22, 2021	BUY	$153.07 - $170.48 $127,660 - $142,180	834 Added 1.05%	80,335 $13.2 Million
Q4 2020 Feb 01, 2021	BUY	$137.11 - $157.38 $137,795 - $158,166	1,005 Added 1.28%	79,501 $12.5 Million
Q3 2020 Oct 23, 2020	SELL	$140.38 - $153.83 $141,643 - $155,214	-1,009 Reduced 1.27%	78,496 $11.7 Million
Q2 2020 Jul 27, 2020	SELL	$128.81 - $155.51 $34,005 - $41,054	-264 Reduced 0.33%	79,505 $11.2 Million
Q1 2020 Apr 23, 2020	SELL	$111.14 - $153.99 $27,785 - $38,497	-250 Reduced 0.31%	79,769 $10.5 Million
Q4 2019 Jan 24, 2020	BUY	$127.5 - $146.44 $261,247 - $300,055	2,049 Added 2.63%	80,019 $11.7 Million
Q3 2019 Oct 25, 2019	SELL	$126.95 - $142.14 $53,065 - $59,414	-418 Reduced 0.53%	77,970 $10.1 Million
Q2 2019 Jul 26, 2019	SELL	$131.15 - $144.24 $66,886 - $73,562	-510 Reduced 0.65%	78,388 $10.9 Million
Q1 2019 Apr 29, 2019	SELL	$125.72 - $139.79 $516,960 - $574,816	-4,112 Reduced 4.95%	78,898 $11 Million
Q4 2018 Jan 28, 2019	SELL	$122.84 - $147.84 $7,370 - $8,870	-60 Reduced 0.07%	83,010 $10.7 Million
Q3 2018 Oct 26, 2018	SELL	$121.58 - $142.88 $630,757 - $741,261	-5,188 Reduced 5.88%	83,070 $11.5 Million
Q2 2018 Aug 06, 2018	BUY	$119.4 - $131.76 $45,610 - $50,332	382 Added 0.43%	88,258 $10.7 Million
Q1 2018 Apr 23, 2018	BUY	$125.1 - $148.14 $306,119 - $362,498	2,447 Added 2.86%	87,876 $11.3 Million
Q4 2017 Jan 26, 2018	SELL	$131.22 - $143.62 $81,750 - $89,475	-623 Reduced 0.72%	85,429 $11.9 Million
Q3 2017 Oct 20, 2017	BUY	$129.47 - $135.38 $11.1 Million - $11.6 Million	86,052	86,052 $11.2 Million

Others Institutions Holding JNJ

# of Institutions

4,275

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $381B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tufton Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Tufton Capital Management with notifications on news.

Account

Tufton Capital Management Johnson & Johnson Transaction History